QPS can assist pharmaceutical and biotechnology companies to effectively integrate pharmacogenomics into their drug development programs to deliver safer and more effective candidates to the market in a timely fashion. The Molecular Biology Group at QPS Pharmaceutical Services is a full-service,
GLP-compliant contract research group providing a wide range of genomic services.

QPS has assembled a group of scientists with a broad range of expertise and practical experience in a wide range of disciplines. Our experienced staff strives to provide clients with the highest quality data and consultative services. We have assembled best-in-class instrumentation, platforms, and processes that are necessary in today's market to conduct steps of the drug discovery and development process in a proper and cost effective way.

QPS Pharmaceutical Services provides a broad range of flexible, tailored service solutions on multiple platforms capable of handling from one to thousands of samples. QPS provides an environment where scientists collaborate with our clients to develop creative solutions.

Located at our Newark, Delaware facility the Molecular Biology Department offers a wide variety of molecular biology services to meet our clients' needs for integration of pharmacogenomics into clinical drug development. Our services include automated RNA and DNA isolation, genotyping and genetic mutation analysis, gene expression profiling analysis, quantitative determination of CpG methylation, viral load determination as well as custom assays to meet your needs. Our laboratory is equipped with state-of-the-art instruments (Applied Biosystems®, Affymetrix®, Qiagen and Pyrosequencing platforms) and our staff strives to apply their vast experience in order to provide clients with the highest quality test results and consultative services. For further information, please contact your Business Development Director.

As you learn more about QPS you will discover why leading biotech and pharmaceutical companies rely on us to help them through the drug discovery and development process.